The shares were sold at an average price of $50.63, for a total transaction of $629,280.27. The stock decreased 0.03% or $0.01 during the last trading session, reaching $37.35. About 455,945 shares traded. Rayonier Inc. (RYN) has risen 11.93% since January 13, 2017 and is uptrending. It has outperformed by 104.70% the S&P500.
Zacks Investment Research upgraded shares of CONMED (NASDAQ:CNMD) from a hold rating to a buy rating in a research note issued to investors on Wednesday, January 3rd. CONMED Corporation had a net margin of 1.92% and a return on equity of 8.38%. The 1-year high was reported on Jan, 13 by Barchart.com. CONMED presently has a consensus rating of Hold and a consensus target price of $53.00.
The stock increased 0.57% or $0.32 during the last trading session, reaching $56.48. About 138,631 shares traded or 23.09% up from the average. Needham & Company LLC reaffirmed a "buy" rating and set a $58.00 target price on shares of CONMED in a report on Friday, November 17th. It has outperformed by 10.89% the S&P500. As per Monday, July 24, the company rating was maintained by Stifel Nicolaus. 258.81 million shares or 4.21% more from 248.36 million shares in 2017Q2 were reported.
Since September 13, 2017, it had 0 buys, and 2 insider sales for $247,258 activity. The rating was maintained by KeyBanc Capital Markets on Wednesday, August 23 with "Hold". Stockholders of record on Friday, December 15th were issued a $0.20 dividend. The insider Forrest Stephen R sold $214,680. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. Therefore 32% are positive. J. M. Smucker Company had 65 analyst reports since August 19, 2015 according to SRatingsIntel. The stock of Applied Materials, Inc. KeyCorp reaffirmed a hold rating on shares of CONMED in a research note on Friday, November 3rd. As per Thursday, April 28, the company rating was maintained by Needham. The stock of CONMED Corporation (NASDAQ:CNMD) earned "Buy" rating by Ladenburg Thalmann on Monday, October 12. BidaskClub lowered CONMED from a "hold" rating to a "sell" rating in a research note on Tuesday, December 12th. The firm has "Buy" rating given on Thursday, July 27 by Needham. (NASDAQ:AMAT) rating on Friday, June 10. RBC Capital Markets has "Sector Perform" rating and $26 target. The company was upgraded on Tuesday, January 19 by CLSA.
Analysts await Applied Materials, Inc. (NYSE:RYN) to report earnings on February, 14. They expect $0.97 EPS, up 44.78% or $0.30 from last year's $0.67 per share. The medical technology company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.01.
Investors sentiment increased to 1.34 in Q3 2017. Its up 0.24, from 0.82 in 2017Q2. Wells Fargo Mn reported 40,224 shares or 0% of all its holdings. 16 funds opened positions while 51 raised stakes. Endurance Wealth Mgmt stated it has 0.02% of its portfolio in The J.M. Smucker Company (NYSE:SJM). Citigroup holds 402 shares or 0% of its portfolio. Texan invested in 11,418 shares or 0.79% of the stock. Invest Counselors Of Maryland Ltd Liability Company reported 0.81% stake. Westwood Corp Il has 0.43% invested in Applied Materials, Inc. (NASDAQ:AMAT) for 297,521 shares. Reynders Mcveigh Mngmt Ltd has 9,369 shares for 0.06% of their portfolio. Tower Rech Capital Ltd Liability Co (Trc) holds 2,810 shares.
Among 6 analysts covering CONMED Corporation (NASDAQ:CNMD), 3 have Buy rating, 0 Sell and 3 Hold. Barclays Public Limited has invested 0% in CONMED Corporation (NASDAQ:CNMD). (NASDAQ:AMAT). Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 480,681 shares. Guardian Capital Lp invested in 0.01% or 8,951 shares.
Polar Securities Inc increased Ttm Technologies Inc (Prn) stake by 5.00 million shares to 25.00M valued at $42.27 million in 2017Q3. Travelers Inc has 343,432 shares for 7.35% of their portfolio. Nxp Semiconductors N V (NASDAQ:NXPI) was raised too. 3,000 shares were sold by GOLDEN JO ANN, worth $150,000. $7,996 worth of stock was bought by Farkas Charles on Wednesday, January 3. Fenimore Asset Mngmt has 0.01% invested in CONMED Corporation (NASDAQ:CNMD) for 7,087 shares. Gsa Capital Prtn Llp invested in 20,231 shares or 0.07% of the stock. CNMD's profit will be $18.16M for 21.72 P/E if the $0.65 EPS becomes a reality. Moreover, Mosaic Financial Partners Inc. has 2.99% invested in the company for 168,328 shares.
CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $14.10 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue fix sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues. It has a 102.88 P/E ratio. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.